Low plasma DHEA-S increases mortality risk among male hemodialysis patients

Heng Jung Hsu, Chiung Hui Yen, Chih Ken Chen, Kuang Hung Hsu, Cheng Cheng Hsiao, Chin Chan Lee, I. Wen Wu, Chiao Yin Sun, Chia Chi Chou, Ming Fang Hsieh, Chun Yu Chen, Chiao Ying Hsu, Chi Jen Tsai, Mai Szu Wu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The incidence of chronic kidney disease (CKD) is on the rise. CKD patients are at high risk of cardiovascular (CVD) and all-cause mortality. CKD patients have several endocrine disorders, including low levels of dehydroepiandrosterone sulfate (DHEA-S). In the general population, low levels of DHEA-S are associated with high CVD and all-cause mortality. The aim of this study was to analyze the prognostic value of plasma DHEA-S on the survival of CKD patients on hemodialysis. Method: This was a single-center prospective cohort study on two hundred CKD patients on hemodialysis, which assessed the prognostic value of plasma DHEA-S on their survival. Result: We found that plasma DHEA-S levels were negatively associated with age, and positively associated with dialysis duration and plasma creatinine, albumin, and phosphate levels in hemodialysis men. Elderly patients with co-morbidities (i.e. diabetes mellitus, congestive heart failure, and chronic obstructive pulmonary disease), poorer fluid control which was evaluated by higher cardiothoracic ratio, and low plasma creatinine and albumin levels seemed to have poor prognosis in hemodialysis men. Furthermore, low plasma DHEA-S levels were significantly associated with CVD-related [hazard ratio (HR) = 3.877; P=0.021], non-CVD-related (HR = 3.522; P=0.016), and all-cause mortality (HR = 3.667; P=0.001) in hemodialysis men. But low plasma DHEA-S levels were not significantly associated with CVD-related, non-CVD-related, and all-cause mortality in hemodialysis women. Multivariate Cox regression analysis suggested that low plasma DHEA-S levels are significantly and independently associated with all-cause mortality in hemodialysis men (HR = 2.933; P=0.033). Conclusion: The study suggested that low plasma DHEA-S was independently and significantly associated with all-cause mortality in CKD hemodialysis men.

Original languageEnglish
Pages (from-to)950-957
Number of pages8
JournalExperimental Gerontology
Volume47
Issue number12
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Dehydroepiandrosterone Sulfate
Renal Dialysis
Chronic Renal Insufficiency
Plasmas
Mortality
Chemical vapor deposition
Hazards
Serum Albumin
Albumins
Creatinine
Pulmonary diseases
Survival
Dialysis
Medical problems
Regression analysis
Chronic Obstructive Pulmonary Disease
Diabetes Mellitus
Cohort Studies
Heart Failure
Phosphates

Keywords

  • Cardiovascular disease
  • Chronic kidney disease
  • Dehydroepiandrosterone sulfate
  • Hemodialysis
  • Mortality

ASJC Scopus subject areas

  • Ageing
  • Biochemistry
  • Cell Biology
  • Endocrinology
  • Genetics
  • Molecular Biology

Cite this

Low plasma DHEA-S increases mortality risk among male hemodialysis patients. / Hsu, Heng Jung; Yen, Chiung Hui; Chen, Chih Ken; Hsu, Kuang Hung; Hsiao, Cheng Cheng; Lee, Chin Chan; Wu, I. Wen; Sun, Chiao Yin; Chou, Chia Chi; Hsieh, Ming Fang; Chen, Chun Yu; Hsu, Chiao Ying; Tsai, Chi Jen; Wu, Mai Szu.

In: Experimental Gerontology, Vol. 47, No. 12, 12.2012, p. 950-957.

Research output: Contribution to journalArticle

Hsu, HJ, Yen, CH, Chen, CK, Hsu, KH, Hsiao, CC, Lee, CC, Wu, IW, Sun, CY, Chou, CC, Hsieh, MF, Chen, CY, Hsu, CY, Tsai, CJ & Wu, MS 2012, 'Low plasma DHEA-S increases mortality risk among male hemodialysis patients', Experimental Gerontology, vol. 47, no. 12, pp. 950-957. https://doi.org/10.1016/j.exger.2012.08.012
Hsu, Heng Jung ; Yen, Chiung Hui ; Chen, Chih Ken ; Hsu, Kuang Hung ; Hsiao, Cheng Cheng ; Lee, Chin Chan ; Wu, I. Wen ; Sun, Chiao Yin ; Chou, Chia Chi ; Hsieh, Ming Fang ; Chen, Chun Yu ; Hsu, Chiao Ying ; Tsai, Chi Jen ; Wu, Mai Szu. / Low plasma DHEA-S increases mortality risk among male hemodialysis patients. In: Experimental Gerontology. 2012 ; Vol. 47, No. 12. pp. 950-957.
@article{e5cbc0e0f2074cf3a00bfe1a97aa768c,
title = "Low plasma DHEA-S increases mortality risk among male hemodialysis patients",
abstract = "Objective: The incidence of chronic kidney disease (CKD) is on the rise. CKD patients are at high risk of cardiovascular (CVD) and all-cause mortality. CKD patients have several endocrine disorders, including low levels of dehydroepiandrosterone sulfate (DHEA-S). In the general population, low levels of DHEA-S are associated with high CVD and all-cause mortality. The aim of this study was to analyze the prognostic value of plasma DHEA-S on the survival of CKD patients on hemodialysis. Method: This was a single-center prospective cohort study on two hundred CKD patients on hemodialysis, which assessed the prognostic value of plasma DHEA-S on their survival. Result: We found that plasma DHEA-S levels were negatively associated with age, and positively associated with dialysis duration and plasma creatinine, albumin, and phosphate levels in hemodialysis men. Elderly patients with co-morbidities (i.e. diabetes mellitus, congestive heart failure, and chronic obstructive pulmonary disease), poorer fluid control which was evaluated by higher cardiothoracic ratio, and low plasma creatinine and albumin levels seemed to have poor prognosis in hemodialysis men. Furthermore, low plasma DHEA-S levels were significantly associated with CVD-related [hazard ratio (HR) = 3.877; P=0.021], non-CVD-related (HR = 3.522; P=0.016), and all-cause mortality (HR = 3.667; P=0.001) in hemodialysis men. But low plasma DHEA-S levels were not significantly associated with CVD-related, non-CVD-related, and all-cause mortality in hemodialysis women. Multivariate Cox regression analysis suggested that low plasma DHEA-S levels are significantly and independently associated with all-cause mortality in hemodialysis men (HR = 2.933; P=0.033). Conclusion: The study suggested that low plasma DHEA-S was independently and significantly associated with all-cause mortality in CKD hemodialysis men.",
keywords = "Cardiovascular disease, Chronic kidney disease, Dehydroepiandrosterone sulfate, Hemodialysis, Mortality",
author = "Hsu, {Heng Jung} and Yen, {Chiung Hui} and Chen, {Chih Ken} and Hsu, {Kuang Hung} and Hsiao, {Cheng Cheng} and Lee, {Chin Chan} and Wu, {I. Wen} and Sun, {Chiao Yin} and Chou, {Chia Chi} and Hsieh, {Ming Fang} and Chen, {Chun Yu} and Hsu, {Chiao Ying} and Tsai, {Chi Jen} and Wu, {Mai Szu}",
year = "2012",
month = "12",
doi = "10.1016/j.exger.2012.08.012",
language = "English",
volume = "47",
pages = "950--957",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Low plasma DHEA-S increases mortality risk among male hemodialysis patients

AU - Hsu, Heng Jung

AU - Yen, Chiung Hui

AU - Chen, Chih Ken

AU - Hsu, Kuang Hung

AU - Hsiao, Cheng Cheng

AU - Lee, Chin Chan

AU - Wu, I. Wen

AU - Sun, Chiao Yin

AU - Chou, Chia Chi

AU - Hsieh, Ming Fang

AU - Chen, Chun Yu

AU - Hsu, Chiao Ying

AU - Tsai, Chi Jen

AU - Wu, Mai Szu

PY - 2012/12

Y1 - 2012/12

N2 - Objective: The incidence of chronic kidney disease (CKD) is on the rise. CKD patients are at high risk of cardiovascular (CVD) and all-cause mortality. CKD patients have several endocrine disorders, including low levels of dehydroepiandrosterone sulfate (DHEA-S). In the general population, low levels of DHEA-S are associated with high CVD and all-cause mortality. The aim of this study was to analyze the prognostic value of plasma DHEA-S on the survival of CKD patients on hemodialysis. Method: This was a single-center prospective cohort study on two hundred CKD patients on hemodialysis, which assessed the prognostic value of plasma DHEA-S on their survival. Result: We found that plasma DHEA-S levels were negatively associated with age, and positively associated with dialysis duration and plasma creatinine, albumin, and phosphate levels in hemodialysis men. Elderly patients with co-morbidities (i.e. diabetes mellitus, congestive heart failure, and chronic obstructive pulmonary disease), poorer fluid control which was evaluated by higher cardiothoracic ratio, and low plasma creatinine and albumin levels seemed to have poor prognosis in hemodialysis men. Furthermore, low plasma DHEA-S levels were significantly associated with CVD-related [hazard ratio (HR) = 3.877; P=0.021], non-CVD-related (HR = 3.522; P=0.016), and all-cause mortality (HR = 3.667; P=0.001) in hemodialysis men. But low plasma DHEA-S levels were not significantly associated with CVD-related, non-CVD-related, and all-cause mortality in hemodialysis women. Multivariate Cox regression analysis suggested that low plasma DHEA-S levels are significantly and independently associated with all-cause mortality in hemodialysis men (HR = 2.933; P=0.033). Conclusion: The study suggested that low plasma DHEA-S was independently and significantly associated with all-cause mortality in CKD hemodialysis men.

AB - Objective: The incidence of chronic kidney disease (CKD) is on the rise. CKD patients are at high risk of cardiovascular (CVD) and all-cause mortality. CKD patients have several endocrine disorders, including low levels of dehydroepiandrosterone sulfate (DHEA-S). In the general population, low levels of DHEA-S are associated with high CVD and all-cause mortality. The aim of this study was to analyze the prognostic value of plasma DHEA-S on the survival of CKD patients on hemodialysis. Method: This was a single-center prospective cohort study on two hundred CKD patients on hemodialysis, which assessed the prognostic value of plasma DHEA-S on their survival. Result: We found that plasma DHEA-S levels were negatively associated with age, and positively associated with dialysis duration and plasma creatinine, albumin, and phosphate levels in hemodialysis men. Elderly patients with co-morbidities (i.e. diabetes mellitus, congestive heart failure, and chronic obstructive pulmonary disease), poorer fluid control which was evaluated by higher cardiothoracic ratio, and low plasma creatinine and albumin levels seemed to have poor prognosis in hemodialysis men. Furthermore, low plasma DHEA-S levels were significantly associated with CVD-related [hazard ratio (HR) = 3.877; P=0.021], non-CVD-related (HR = 3.522; P=0.016), and all-cause mortality (HR = 3.667; P=0.001) in hemodialysis men. But low plasma DHEA-S levels were not significantly associated with CVD-related, non-CVD-related, and all-cause mortality in hemodialysis women. Multivariate Cox regression analysis suggested that low plasma DHEA-S levels are significantly and independently associated with all-cause mortality in hemodialysis men (HR = 2.933; P=0.033). Conclusion: The study suggested that low plasma DHEA-S was independently and significantly associated with all-cause mortality in CKD hemodialysis men.

KW - Cardiovascular disease

KW - Chronic kidney disease

KW - Dehydroepiandrosterone sulfate

KW - Hemodialysis

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=84868302071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868302071&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2012.08.012

DO - 10.1016/j.exger.2012.08.012

M3 - Article

C2 - 22974561

AN - SCOPUS:84868302071

VL - 47

SP - 950

EP - 957

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

IS - 12

ER -